Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 296 entries
View as:

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05765851 Org: User:
Start: 05/30/23 End: 06/30/26 Due: 06/30/27

Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a

Phase: N/A Priority: Normal
NCT ID: NCT02261376 Org: User:
Start: 09/30/14 End: 11/30/14 Due: 11/30/15

Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00989261 Org: User:
Start: 11/30/09 End: 12/31/14 Due: 12/31/15

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00717769 Org: User:
Start: 07/16/08 End: 04/09/09 Due: 04/09/10

Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )

Phase: N/A Priority: Normal
NCT ID: NCT02633800 Org: User:
Start: 12/22/15 End: 02/21/18 Due: 02/21/19

DS1040b/Aspirin Drug/Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT02071004 Org: User:
Start: 01/31/14 End: 02/28/14 Due: 02/28/15

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01756898 Org: User:
Start: 11/28/12 End: 01/14/14 Due: 01/14/15

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02586233 Org: User:
Start: 09/30/15 End: 08/13/19 Due: 08/13/20

A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT01877382 Org: User:
Start: 07/11/13 End: 12/03/20 Due: 12/03/21

Edoxaban in Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT01802775 Org: User:
Start: 02/06/13 End: 12/03/14 Due: 12/03/15

A Study of Quizartinib Pharmacokinetics in Participants With Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04473664 Org: User:
Start: 09/22/20 End: 07/22/21 Due: 07/22/22

Study of an Experimental New Drug, PPARĪ³ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00408434 Org: User:
Start: 11/30/06 End: 02/28/10 Due: 02/28/11

Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01149720 Org: User:
Start: 07/31/10 End: 03/31/11 Due: 03/31/12

The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00330135 Org: User:
Start: 01/31/05 End: 03/31/07 Due: 03/31/08

A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China

Phase: N/A Priority: Normal
NCT ID: NCT06585501 Org: User:
Start: 08/15/24 End: 07/18/25 Due: 07/18/26

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

Phase: N/A Priority: Normal
NCT ID: NCT04484142 Org: User:
Start: 03/30/21 End: 12/12/25 Due: 12/12/26

Effects of Multiple Doses of CS-8080 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00796575 Org: User:
Start: 11/30/08 End: 12/31/08 Due: 12/31/09

A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00382213 Org: User:
Start: 06/30/00 End: 12/31/04 Due: 12/31/05

A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01349036 Org: User:
Start: 12/03/11 End: 11/05/13 Due: 11/05/14

Food Effects on Milademetan Pharmacokinetics in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03647202 Org: User:
Start: 08/16/18 End: 09/13/18 Due: 09/13/19

Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT02107885 Org: User:
Start: 03/31/14 End: 07/31/14 Due: 07/31/15

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Phase: N/A Priority: Normal
NCT ID: NCT05555732 Org: User:
Start: 01/11/23 End: 08/01/27 Due: 08/01/28

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01244191 Org: User:
Start: 01/11/11 End: 12/15/12 Due: 12/15/13

A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02790671 Org: User:
Start: 05/31/16 End: 06/30/16 Due: 06/30/17

Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01101334 Org: User:
Start: 03/31/10 End: 04/30/13 Due: 04/30/14